South and Central America Hypertrophic and Keloid Scar Treatment Market Growth by 2027

South and Central America Hypertrophic and Keloid Scar Treatment Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Scar Type (Hypertrophic and Keloid), Product Type (Laser Products, Topical Products, Injectables, Other Products), and End User (Hospitals, Clinics, and Homecare)

Historic Data: 2018-2019 | Base Year: 2020 | Forecast Period: 2021-2027
  • Status : Published
  • Report Code : TIPRE00025200
  • Category : Life Sciences
  • No. of Pages : 88
  • Available Report Formats : pdf-format excel-format
  • Last update date : October 07, 2021
South and Central America Hypertrophic and Keloid Scar Treatment Market Growth by 2027
Report Date: October 07, 2021   |   Report Code: TIPRE00025200 Email: sales@theinsightpartners.com

2020 Market Size

US$ 248.42 Mn

Base year value

2027 Forecast

US$ 477.69 Mn

Projected by 2027

CAGR 2021-2027

9.8 %

Growth rate

Addressable Market

US$ 2,571.93 Mn

(2021-2027)

The hypertrophic and keloid scar treatment market in South and Central America is expected to grow from US$ 248.42 million in 2020 to US$ 477.69 million by 2027; it is estimated to grow at a CAGR of 9.8% from 2020 to 2027.



Brazil and Argentina are major economies in South and Central America. Emerging treatments modalities is the major factor driving the growth of the South and Central America hypertrophic and keloid scar treatment market. At present, there are various treatments available to treat hypertrophic and keloid scars. The emerging treatments are based on stem cell therapy, verapamil, mitomycin C (MMC), interferons, bleomycin, ACE inhibitors, and botulinum toxin type A. Most of these treatments have shown promising results. On the other hand, the topical products are being used to reduce the thickness of scars and lighten them as they are esthetically unpleasing. However, laser treatment and radiotherapy are associated with side effects, and they do not heal the scars completely. Therefore, researchers are continuously studying these treatments and are yet to derive a standard treatment for hypertrophic and keloid scars. Likewise, manufacturers are also engaged in developing products such as extracellular-matrix that control the proliferation of collagen, thereby preventing the excess deposition of the same. Keloid scars can also be related to genetic factors; hence, they are considered major clinical challenges. Therefore, the ongoing research and developments are likely to provide preventive measures and extraordinary treatments for hypertrophic and keloid scars treatment during the forecast period, which is further anticipated to drive the market in South and Central America.

South and Central America has witnessed a growing number of cases of COVID-19 since its outbreak. For example, according to the Worldometer, the number of cases reached 13,382,026, with 366,256 recorded deaths in South America as of January 2021. In Brazil, the first case of COVID-19 was confirmed on February 26, 2020, and now, the cases have reached 7,754,560, with 196,591 deaths. Argentina and Colombia reached 1,648,940 and 1,686,131 cases of COVID-19 as of January 2021. COVID-19 is predicted to result in the region's worst recession, causing the region's GDP to contract by 9.1% in 2020. This is projected to increase the number of poor by 45 million and the highly poor by 28 million. The COVID‐19 pandemic is a vital test for the still overburdened and underfunded public health systems of South and Central America. Moreover, it will decrease imports due to disruptions in global trade, further increasing the scarcity of medical supplies and other goods, resulting in a significant price increase.
24877-img1

  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

South and Central America Hypertrophic and Keloid Scar Treatment Market Segmentation

South and Central America Hypertrophic and Keloid Scar Treatment Market – By Scar Type

  • Hypertrophic
  • Keloid

South and Central America Hypertrophic and Keloid Scar Treatment Market – By Product Type

  • Injectables
  • Topical
    • Gels
    • Silicone Sheets
    • Creams
    • Other
  • Laser
    • CO2
    • Pulse-Dyed
    • Other
  • Other

South and Central America Hypertrophic and Keloid Scar Treatment Market – By End User

  • Hospitals
  • Clinics
  • Homecare

South and Central America Hypertrophic and Keloid Scar Treatment Market, by Country

  • Brazil
  • Argentina
  • Rest of South & Central America

South and Central America Hypertrophic and Keloid Scar Treatment Market-Companies Mentioned

  • Alliance Pharma PLC
  • HRA Pharma
  • Mölnlycke Health Care AB.
  • Newmedical Technology Inc.
  • Perrigo Company plc
  • Smith & Nephew
  • Sonoma Pharmaceuticals, Inc
  • Suneva Medical

South and Central America Hypertrophic and Keloid Scar Treatment Report Scope

Report Attribute Details
Market size in 2020 US$ 248.42 Million
Market Size by 2027 US$ 477.69 Million
CAGR (2020 - 2027) 9.8%
Historical Data 2018-2019
Forecast period 2021-2027
Segments Covered By Scar Type
  • Hypertrophic and Keloid
By Product Type
  • Laser Products
  • Topical Products
  • Injectables
  • Other Products
By End User
  • Hospitals
  • Clinics
  • Homecare
Regions and Countries Covered South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Market leaders and key company profiles
  • Alliance Pharma PLC
  • HRA Pharma
  • M
Trupti Wadekar
Assistant Manager,
Market Research & Consulting

Trupti is a senior consultant with over 10 years of experience in the Healthcare sector, specializing in pharmaceuticals, biotechnology, and life-sciences markets. She holds a Bachelor’s degree in Biotechnology and an MBA with dual specialization in Marketing and Pharmaceuticals & Biotechnology, combining a strong scientific foundation with a strategic and commercial perspective. Her professional experience encompasses market research, competitive intelligence, strategic advisory, and business development, supporting clients across diverse and evolving healthcare markets.

She has worked extensively on market sizing and assessment, growth strategy, market expansion, and strategic decision-making initiatives, helping clients identify opportunities and address complex business challenges. Trupti brings strong expertise in client engagement, stakeholder management, team leadership, and translating research findings into actionable business insights. Her ability to connect scientific understanding with market dynamics and commercial strategy enables her to deliver practical, high-impact solutions aligned with client objectives.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA